Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
31JUL

Odyssey Ventures gets £10m state cheque

1 min read
12:32UTC

The British Business Bank committed £10m on 23 July to Odyssey Ventures, a $50m seed fund run from London and San Francisco to get UK founders American capital early.

TechnologyDeveloping
Key takeaway

British state money is now buying UK founders an early route into American capital and customers.

The British Business Bank, the UK Government's state-owned development bank, committed £10 million to Odyssey Ventures on Thursday 23 July⁠1. The cheque came through its Regional Angels Programme.

Odyssey Discovery I is a $50 million pre-seed and seed fund, the earliest institutional cheques a company takes, run from London and San Francisco by Ali Mitchell and Michelle Robson. Odyssey's own pitch names the problem it is solving: give UK founders American capital, customers and operating support before better-capitalised US competitors take the market from them.

That is a state institution funding an exit ramp. The reasoning is defensible, since a British company that reaches US customers and US follow-on money early is more likely to still exist at Series B. The trade is that the relationships built at pre-seed tend to determine where the company later domiciles, lists and hires. Capital moves the other way too, and without a state intermediary: PhysicsX took a Series C led by Singapore's Temasek in June without leaving the UK. Four days later the same Bank reported a very different instrument, one designed to buy depth at home rather than reach abroad.

Deep Analysis

In plain English

The British Business Bank is the UK Government's development bank. It put £10m into a new investment fund called Odyssey Ventures, which is unusual because the fund is run jointly from London and San Francisco and plans to invest in very early-stage companies (pre-seed and seed stage) on both sides of the Atlantic. The £10m is part of a wider $50m fund, so the government's money is one piece of a larger pot that other investors are also contributing to.

Deep Analysis
Root Causes

The British Business Bank's Regional Angels Programme funds through the Bank's existing fund-of-funds model rather than through its newer £6.6bn direct-investment mandate, which explains why this £10m commitment sits well below the £60m-per-company ceiling that mandate allows.

Odyssey Ventures receives the Bank's money as a limited partner, the same structure the Bank used for Seedcamp's $320m raise in June, rather than as a direct equity stake in any single startup.

What could happen next?
  • Meaning

    Backing a transatlantic fund rather than a UK-only vehicle signals the Bank is willing to fund UK founders' access to US capital networks rather than insisting investment stay domestically routed.

First Reported In

Update #13 · Humanoid hit $1.35bn on a customer order

British Business Bank· 31 Jul 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.